9-17787382-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_003026.5(SH3GL2):c.334C>T(p.Pro112Ser) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000682 in 1,612,586 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003026.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SH3GL2 | NM_003026.5 | c.334C>T | p.Pro112Ser | missense_variant, splice_region_variant | 5/9 | ENST00000380607.5 | NP_003017.1 | |
SH3GL2 | XM_011518005.4 | c.436C>T | p.Pro146Ser | missense_variant, splice_region_variant | 5/9 | XP_011516307.1 | ||
SH3GL2 | XM_047423730.1 | c.229C>T | p.Pro77Ser | missense_variant, splice_region_variant | 5/9 | XP_047279686.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SH3GL2 | ENST00000380607.5 | c.334C>T | p.Pro112Ser | missense_variant, splice_region_variant | 5/9 | 1 | NM_003026.5 | ENSP00000369981 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151998Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1460588Hom.: 0 Cov.: 29 AF XY: 0.00000688 AC XY: 5AN XY: 726678
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151998Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74238
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 14, 2022 | The c.334C>T (p.P112S) alteration is located in exon 5 (coding exon 5) of the SH3GL2 gene. This alteration results from a C to T substitution at nucleotide position 334, causing the proline (P) at amino acid position 112 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at